Sandu Pharmaceuticals soars on incorporating wholly owned subsidiary

Sandu Pharmaceuticals is currently trading at Rs. 72.10, up by 2.80 points or 4.04% from its previous closing of Rs. 69.30 on the BSE.

The scrip opened at Rs. 73.70 and has touched a high and low of Rs. 73.70 and Rs. 72.10 respectively. So far 943 shares were traded on the counter.

Sandu Pharmaceuticals
Sandu Pharmaceuticals

The BSE group ‘X’ stock of face value Rs. 10 has touched a 52 week high of Rs. 86.00 on 26-Apr-2022 and a 52 week low of Rs. 43.35 on 21-Dec-2021.

Last one week high and low of the scrip stood at Rs. 75.60 and Rs. 64.55 respectively. The current market cap of the company is Rs. 61.06 crore.

The promoters holding in the company stood at 50.43%, while Institutions and Non-Institutions held 0.01% and 49.56% respectively.

Sandu Pharmaceuticals has incorporated a wholly owned subsidiary named ‘Sandu Phytoceuticals’ on July 27, 2022. The wholly owned subsidiary company incorporated in India shall carry out business in the field of Pharmaceuticals/ Phytoceuticals Products.

Sandu Pharmaceuticals, popularly called by people Sandu Ayurveda, is one of the renewed brands when it’s come to Ayurvedic health care Products or Medicines.

Leave a Comment